Evidence map›Paper›PMID 35175428›Full record

ArticleMolecular genetics and genomics : MGG2022

Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma.

João Basso, Marco G Paggi, Ana Fortuna, Carla Vitorino, Rui Vitorino

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. miRNA in Molecular Diagnostics.Bioengineering (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

João BassoFaculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Marco G PaggiCellular Networks and Molecular Therapeutic Targets, Proteomics Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.
Ana FortunaFaculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Carla VitorinoFaculty of Pharmacy, University of Coimbra, Coimbra, Portugal. csvitorino@ff.uc.pt.ORCID http://orcid.org/0000-0003-3424-548X
Rui VitorinoiBiMED-Department of Medical Sciences, University of Aveiro, Aveiro, Portugal. rvitorino@ua.pt.
University of Coimbra · PTUniversidade do Porto · PT

Funding

Fundação para a Ciência e a Tecnologia IF/00286/2015Fundação para a Ciência e a Tecnologia POCI-01-0145-FEDER-007628Fundação para a Ciência e a Tecnologia SFRH/BD/149138/2019Fundação para a Ciência e a Tecnologia UIDB/04501/2020Fundação para a Ciência e a Tecnologia UIDB/50006/2020Fundação para a Ciência e a Tecnologia UID/IC/00051/2019Fundação para a Ciência e a Tecnologia UID/QUI/00313/2020
6 · The paper itself

Abstract

MicroRNAs are endogenous non-coding RNAs with a marked impact on the development and progression of brain tumors. However, they commonly share different expression patterns in other types of tumors, thereby exhibiting lack of tissue specificity. Here, an integrative holistic analysis of microarray data is established for deciphering dysregulated miRNAs in glioblastoma, distinguishing them from eight other CNS tumors. The identification of dysregulated miRNAs was performed in a pool of 176 patients, 118 of which diagnosed with glioblastoma. Dysregulated miRNAs commonly expressed in glioblastoma were then discriminated from those co-expressed in other CNS tumors and further characterized. Overall, 21 miRNAs were found to be commonly dysregulated in glioblastoma. Notwithstanding, 16 miRNAs also exhibited a differential expression in at least one other CNS tumor. The remaining 5, specifically, hsa-miR-21-3p, hsa-miR-338-5p, hsa-miR-485-5p, hsa-miR-491-5p and hsa-miR-1290, were solely associated to glioblastoma. This signature is in-depth characterized, with the spotlight on tumor progression, invasion and patient survival. These five endogenous molecules, differentially expressed in glioblastoma, are thus suggested as potential therapeutic targets, modulating several genes involved in major signalling pathways, including MAPK/ERK, calcium, PI3K/AKT, mTOR and Wnt. In summary, these findings lay a foundation for further research on the expression and function of specific patterns of miRNAs expression in glioblastoma, providing reference for potential novel targets.

Indexed as

Brain NeoplasmsGlioblastomaMicroRNAsHumansPhosphatidylinositol 3-KinasesSignal TransductionMicroRNAsPhosphatidylinositol 3-KinasesBioinformaticsCNS tumorsDatasetsGlioblastomaGliomamiRNA

Identifiers

PMID35175428
OpenAlexW4213281646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.